Want to see ACHC full AI Analyst Report?
ACHC Stock Chart & Stats
$29.87
$0.50(1.47%)
At close: 4:00 PM EDT
$29.87
$0.50(1.47%)
Day’s Range― - ―
52-Week Range$11.43 - $35.83
Previous Close$34.51
Volume2.30M
Average Volume (3M)1.48M
Market Cap
$2.93B
Enterprise Value$5.30B
Total Cash (Recent Filing)$171.29M
Total Debt (Recent Filing)$2.56B
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Nov 04, 2026EPS Estimate
0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.45
Shares Outstanding93,100,270
10 Day Avg. Volume1,452,739
30 Day Avg. Volume1,483,467
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.39
P/FCF Ratio-2.93
Enterprise Value/Market Cap1.81
Enterprise Value/Revenue1.58
Enterprise Value/Gross Profit4.43
Enterprise Value/Ebitda-7.76
Forecast
1Y Price Target
$35.90Price Target Upside20.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.53
Revenue Forecast (FY)$3.43B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionAcadia is expanding treatment capacity through joint ventures and new facilities, broadening its service footprint and future revenue base. Adding beds across acute and other settings can support durable volume growth as new locations mature, while improving access strengthens the company’s market position.
New Facility EconomicsOutperformance from multiple facility cohorts indicates that Acadia is converting expansion spending into operating contributions more effectively than expected. If this pattern persists, maturing sites can provide recurring EBITDA growth, offset start-up costs, and reinforce the returns from the company’s development model.
Cash Flow And GuidanceThe quarter demonstrated meaningful cash generation and debt reduction, improving financial flexibility despite broader earnings pressure. Management’s expectation for positive second-half free cash flow and its updated operating cash-flow outlook provide a path toward more consistent internal funding of expansion and balance-sheet repair.
Bears Say
Earnings DeteriorationThe sharp swing from 2024 profitability to a large TTM loss shows that Acadia’s earnings power remains volatile and insufficiently stable. Revenue contraction further limits operating leverage, making it harder to fund growth, absorb cost increases, or reduce leverage without relying on operational recovery.
Liability Cost PressureHigher professional liability costs create a recurring drag on margins and cash generation rather than a simple volume issue. Management also said additional actuarial adjustments are difficult to predict, leaving uncertainty around future profitability and making financial planning less dependable over the next several quarters.
Payer TensionPayer disagreements can constrain authorization, treatment duration, service mix, and realized reimbursement across Acadia’s behavioral-health network. Because patient service revenue depends heavily on managed-care contracts, persistent utilization restrictions could limit growth and pressure revenue per patient even when demand remains healthy.
Acadia Healthcare News
ACHC FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was $11.43 and its highest was $35.83 in the past 12 months.
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is $2.93B.
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is Nov 04, 2026 which is in 12 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Jul 28, 2026. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.346 by $0.034.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is 0.46.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 93,100,270 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of $0.38 in its last earnings report, beating expectations of $0.346. Following the earnings report the stock price went down -16.335%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Currently, no hedge funds are holding shares in ACHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Acadia Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$35.90 (20.19% Upside)
$35.90 (20.19% Upside)
Blogger Sentiment
Bullish
ACHC Sentiment 86%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 545.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.89%
12-Months-Change
Fundamentals
Return on Equity
-50.02%
Trailing 12-Months
Asset Growth
-12.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acadia Healthcare
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
ACHC Company Deck
ACHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive: management reported results at or above guidance, strong free cash flow, substantial debt reduction, improving performance from new facilities, operational gains, and confidence in the full-year outlook. Offsetting issues included flat reported revenue, the impact of New York Medicaid changes, a significant professional liability reserve adjustment, CTC performance below expectations, start-up losses, and uncertainty around government investigation costs. The highlights significantly outweighed the lowlights.View all ACHC earnings summariesACHC Stock 12 Month Forecast
Average Price Target
$35.90
▲(20.19% Upside)
Technical Analysis
Community Health
―
HCA Healthcare
―
Healthcare Services
―
Universal Health
―
Lifestance Health Group
―
Ownership Overview
2.12% Insiders
28.37% Mutual Funds
0.70% Other Institutional Investors
31.66% Public Companies and
Individual Investors